Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study

Objective To assess predictors of mortality in a population of people prescribed methadone. Design Retrospective cohort study. Setting Geographically defined population in Tayside, Scotland. Participants 2378 people prescribed and dispensed liquid methadone between January 1993 and February 2004. Main outcome measures All cause mortality (primary outcome) and drug dependent cause specific mortality (secondary outcome) by means of Cox proportional hazards models during 12 years of follow-up. Results Overall, 181 (8%) people died. Overuse of methadone (adjusted hazard ratio 1.67, 95% confidence interval 1.05 to 2.67), history of psychiatric admission (2.47, 1.67 to 3.66), and increasing comorbidity measured as Charlson index ≥3 (1.20, 1.15 to 1.26) were all associated with an increase in all cause mortality. Longer duration of use (adjusted hazard ratio 0.95, 0.94 to 0.96), history of having urine tested (0.33, 0.22 to 0.49), and increasing time since last filled prescription were protective in relation to all cause mortality. Drug dependence was identified as the principal cause of death in 60 (33%) people. History of psychiatric admission was significantly associated with drug dependent death (adjusted hazard ratio 2.41, 1.25 to 4.64), as was history of prescription of benzodiazepines (4.35, 1.32 to 14.30). Conclusions Important elements of care in provision of methadone maintenance treatment are likely to influence, or be a marker for, a person’s risk of death.

[1]  J. Keen.  Managing drug misuse in general practice , 1999, BMJ.

[2]  Eamon Keenan,et al.  Managing drug misuse in general practice , 1999 .

[3]  M. Farré,et al.  Maintenance buprenorphine for opioid users , 2003, The Lancet.

[4]  K. Schulz,et al.  Bias and causal associations in observational research , 2002, The Lancet.

[5]  Duncan Stewart,et al.  A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. , 2002, Addiction.

[6]  R. Ali,et al.  Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS. , 2008, Addiction.

[7]  M. Connock,et al.  Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. , 2007, Health technology assessment.

[8]  M. Hickman,et al.  Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004. , 2006, International journal of epidemiology.

[9]  K. Sporer.  Strategies for preventing heroin overdose , 2003, BMJ : British Medical Journal.

[10]  J. Strang,et al.  Relationship between Prescribing and Risk of Opiate Overdose among Drug Users in and out of Maintenance Treatment , 2003, European Addiction Research.

[11]  W. van den Brink,et al.  Management of opioid dependence , 2003 .

[12]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[13]  J. Marsden,et al.  The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results. , 2003, Addiction.

[14]  P. Elliott,et al.  Trends in drug overdose deaths in England and Wales 1993-98: methadone does not kill more people than heroin. , 2003, Addiction.

[15]  Joann Elmore,et al.  Coordinating Care across Diseases, Settings, and Clinicians: A Key Role for the Generalist in Practice , 2005, Annals of Internal Medicine.

[16]  F. Faggiano,et al.  Methadone maintenance at different dosages for opioid dependence. , 2003, The Cochrane database of systematic reviews.

[17]  M. Weinrich,et al.  Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy. , 2000, JAMA.

[18]  M. Farrell.  Reducing Drug Related Deaths , 2002 .

[19]  P. Mehler,et al.  Treating opioid dependence: Growing implications for primary care , 2004 .

[20]  G. Rowse,et al.  Does methadone maintenance treatment based on the new national guidelines work in a primary care setting? , 2003, The British journal of general practice : the journal of the Royal College of General Practitioners.

[21]  N. Mathers,et al.  Deaths from drugs of abuse in Sheffield 1997-1999: what are the implications for GPs prescribing to heroin addicts? , 2002, Family practice.

[22]  L. Rozewicz,et al.  Managing drug misuse in general practice. , 1992, BMJ.

[23]  P. Shekelle,et al.  Systematic Review: Impact of Health Information Technology on Quality, Efficiency, and Costs of Medical Care , 2006, Annals of Internal Medicine.

[24]  M. Stark.  Drug misuse and dependence — guidelines on clinical management , 1999 .

[25]  R P Mattick,et al.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. , 2009, The Cochrane database of systematic reviews.

[26]  K. Mills,et al.  The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). , 2008, Addiction.

[27]  W. Hall,et al.  Challenge of reducing drug-related deaths , 2000, The Lancet.

[28]  Jeff Ward,et al.  Role of maintenance treatment in opioid dependence , 1999, The Lancet.

[29]  H. Quan,et al.  New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. , 2004, Journal of clinical epidemiology.

[30]  T. Fahey,et al.  National Investigation into Drug Related Deaths in Scotland, 2003 , 2005 .

[31]  V. Carstairs,et al.  Deprivation and health in Scotland. , 1990, Health bulletin.

[32]  G. Jackson,et al.  Contribution of problem drug users’ deaths to excess mortality in Scotland: secondary analysis of cohort study , 2008, BMJ : British Medical Journal.

[33]  J. Strang,et al.  Effect of national guidelines on prescription of methadone: analysis of NHS prescription data, England 1990-2001 , 2003, BMJ : British Medical Journal.

[34]  M. Gossop.  Maintenance treatments across countries. , 2008, Addiction.

[35]  S. Love,et al.  Survival Analysis Part III: Multivariate data analysis – choosing a model and assessing its adequacy and fit , 2003, British Journal of Cancer.